BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 33665885)

  • 1. The efficacy of energy-based devices combination therapy for melasma.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment of melasma involving low-fluence Q-switched Nd:YAG laser and fractional microneedling radiofrequency.
    Kwon HH; Choi SC; Jung JY; Park GH
    J Dermatolog Treat; 2019 Jun; 30(4):352-356. PubMed ID: 30160539
    [No Abstract]   [Full Text] [Related]  

  • 3. Retrospective analysis of the treatment of melasma lesions exhibiting increased vascularity with the 595-nm pulsed dye laser combined with the 1927-nm fractional low-powered diode laser.
    Geddes ER; Stout AB; Friedman PM
    Lasers Surg Med; 2017 Jan; 49(1):20-26. PubMed ID: 28134994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of combined treatments for melasma involving energy-based devices and proposed pathogenesis-oriented combinations.
    Mehrabi JN; Bar-Ilan E; Wasim S; Koren A; Zusmanovitch L; Salameh F; Isman Nelkenbaum G; Horovitz T; Zur E; Song Lim T; Mashiah J; Artzi O
    J Cosmet Dermatol; 2022 Feb; 21(2):461-472. PubMed ID: 33794033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians.
    Wattanakrai P; Mornchan R; Eimpunth S
    Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of melasma treatment focusing on laser and light devices.
    Li JY; Geddes ER; Robinson DM; Friedman PM
    Semin Cutan Med Surg; 2016 Dec; 35(4):223-232. PubMed ID: 27918005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of the combination of Q-switched Nd:YAG laser and microneedling for melasma.
    Karadağ Köse Ö; Borlu M
    J Cosmet Dermatol; 2021 Mar; 20(3):769-775. PubMed ID: 32696614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Low-Fluence Q-Switched Nd:YAG Laser Treatment for Melasma: A Systematic Review.
    Lee YS; Lee YJ; Lee JM; Han TY; Lee JH; Choi JE
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-fluence Q-switched Nd:YAG laser for the treatment of melasma in Asian patients.
    Choi JE; Lee DW; Seo SH; Ahn HH; Kye YC
    J Cosmet Dermatol; 2018 Dec; 17(6):1053-1058. PubMed ID: 30280474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evolution of melasma therapy: targeting melanosomes using low-fluence Q-switched neodymium-doped yttrium aluminium garnet lasers.
    Kauvar AN
    Semin Cutan Med Surg; 2012 Jun; 31(2):126-32. PubMed ID: 22640433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melasma: A critical analysis of clinical trials investigating treatment modalities published in the past 10 years.
    Spierings NMK
    J Cosmet Dermatol; 2020 Jun; 19(6):1284-1289. PubMed ID: 31603285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of fractional QSRL and IPL for melasma treatment in Chinese population.
    Tong LG; Wu Y; Wang B; Xu XG; Tu HD; Chen HD; Li YH
    J Cosmet Laser Ther; 2017 Feb; 19(1):13-17. PubMed ID: 27594596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulsed dye laser versus intense pulsed light in melasma: a split-face comparative study.
    Hassan AM; Elfar NN; Rizk OM; Eissa NY
    J Dermatolog Treat; 2018 Nov; 29(7):725-732. PubMed ID: 29455565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of mottled hypopigmentation after low-fluence 1,064-nm Q-switched neodymium-doped yttrium aluminum garnet laser therapy.
    Ryu HJ; Kim J
    J Cosmet Laser Ther; 2013 Oct; 15(5):290-2. PubMed ID: 23464754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of melasma in men with low-fluence Q-switched neodymium-doped yttrium-aluminum-garnet laser versus combined laser and glycolic acid peeling.
    Vachiramon V; Sahawatwong S; Sirithanabadeekul P
    Dermatol Surg; 2015 Apr; 41(4):457-65. PubMed ID: 25760554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers.
    Kauvar AN
    Lasers Surg Med; 2012 Feb; 44(2):117-24. PubMed ID: 22334295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of melasma by 1064-nm Q-switched neodymium:yttrium-aluminum-garnet laser therapy for acquired bilateral nevus of Ota-like macules (Hori nevus): A study on related factors in the Chinese population.
    Wang B; Xie HF; Tan J; Xie HJ; Xu LY; Ding R; Liu FF; Chen X; Jian D; Li J
    J Dermatol; 2016 Jun; 43(6):655-61. PubMed ID: 26777390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation.
    Ko D; Wang RF; Ozog D; Lim HW; Mohammad TF
    J Am Acad Dermatol; 2023 Feb; 88(2):291-320. PubMed ID: 35158001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.